Oxford Endovascular Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$10.2M
- Investors
-
14
Oxford Endovascular General Information
Description
Developer of a neurovascular disease device designed to treat brain aneurysms. The company uses origami engineering to prepare a laser-cut metal alloy device that can be inserted into a patient's brain using a catheter where it expands into a mesh tube that takes the shape of the blood vessel to divert blood flow away from intracranial aneurysms at risk of rupture, enabling healthcare practitioners to treat patients suffering from brain aneurysms by reducing the risk of adverse events.
Contact Information
Website
www.oxfordendovascular.comCorporate Office
- S7 Magdalen Centre, Robert Robinson Avenue
- Oxford Science Park
- Oxford OX4 4GA
- England, United Kingdom
Corporate Office
- S7 Magdalen Centre, Robert Robinson Avenue
- Oxford Science Park
- Oxford OX4 4GA
- England, United Kingdom
Oxford Endovascular Timeline
Oxford Endovascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series A) | 20-May-2024 | $10.2M | Completed | Clinical Trials - General | ||
| 9. Accelerator/Incubator | 01-Jan-2023 | Completed | Clinical Trials - General | |||
| 8. Later Stage VC (Series A) | 08-Apr-2021 | Completed | Clinical Trials - General | |||
| 7. Grant | 16-Nov-2020 | Completed | Pre-Clinical Trials | |||
| 6. Later Stage VC | 15-Sep-2020 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 10-Jul-2020 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 08-Jul-2019 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 05-Apr-2018 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 23-Dec-2015 | $3.01M | $3.01M | Completed | Startup | |
| 1. University Spin-Out | 09-Sep-2015 | Completed | Startup |
Oxford Endovascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 105,000 | $0.012533 | $25.07 | $25.07 | 1x | $25.07 | 18.88% | |
| Ordinary | 133,332 | $0.012533 | $18.8 | $18.8 | 1x | $18.8 | 23.97% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Oxford Endovascular Comparisons
Industry
Financing
Details
Oxford Endovascular Competitors (12)
One of Oxford Endovascular’s 12 competitors is Balt, a Private Equity-Backed company based in Montmorency, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Balt | Private Equity-Backed | Montmorency, France | ||||
| Penumbra | Formerly VC-backed | Alameda, CA | ||||
| Boston Scientific | Corporation | Marlborough, MA | ||||
| Evasc | Formerly VC-backed | Vancouver, Canada | ||||
| Wallaby Medical | Venture Capital-Backed | Shanghai, China |
Oxford Endovascular Patents
Oxford Endovascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023304728-A1 | An expandable tube for deployment within a blood vessel | Pending | 04-Jul-2022 | ||
| EP-4551166-A1 | An expandable tube for deployment within a blood vessel | Pending | 04-Jul-2022 | ||
| GB-202209796-D0 | An expandable tube for deployment within a blood vessel | Inactive | 04-Jul-2022 | ||
| US-20260325324-A1 | An expandable tube for deployment within a blood vessel | Pending | 04-Jul-2022 | ||
| WO-2024009055-A1 | An expandable tube for deployment within a blood vessel | Inactive | 04-Jul-2022 | A61F2/852 |
Oxford Endovascular Signals
Oxford Endovascular Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Global Support Capital | Family Office | Minority | ||
| Norcliffe Capital | Venture Capital | Minority | ||
| Medlim | Accelerator/Incubator | |||
| Additio Investment Group | Venture Capital | Minority | ||
| Vulpes Investment Management | Family Office | Minority |
Oxford Endovascular FAQs
-
When was Oxford Endovascular founded?
Oxford Endovascular was founded in 2015.
-
Where is Oxford Endovascular headquartered?
Oxford Endovascular is headquartered in Oxford, United Kingdom.
-
What is the size of Oxford Endovascular?
Oxford Endovascular has 9 total employees.
-
What industry is Oxford Endovascular in?
Oxford Endovascular’s primary industry is Therapeutic Devices.
-
Is Oxford Endovascular a private or public company?
Oxford Endovascular is a Private company.
-
What is the current valuation of Oxford Endovascular?
The current valuation of Oxford Endovascular is .
-
What is Oxford Endovascular’s current revenue?
The current revenue for Oxford Endovascular is .
-
How much funding has Oxford Endovascular raised over time?
Oxford Endovascular has raised $28.3M.
-
Who are Oxford Endovascular’s investors?
Global Support Capital, Norcliffe Capital, Medlim, Additio Investment Group, and Vulpes Investment Management are 5 of 14 investors who have invested in Oxford Endovascular.
-
Who are Oxford Endovascular’s competitors?
Balt, Penumbra, Boston Scientific, Evasc, and Wallaby Medical are some of the 12 competitors of Oxford Endovascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process